US Patent 9561246 Use of Odiparcil in the treatment of a mucopolysaccharidosis

Patent 9561246 was granted and assigned to Inventiva Pharma on February, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Inventiva Pharma

Current Assignee

Inventiva Pharma

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9561246

Patent Inventor Names

Philippe Masson0

Jean-Louis Junien0

Date of Patent

February 7, 2017

Patent Application Number

14506239

Date Filed

October 3, 2014

Patent Primary Examiner

‌

Dennis Heyer

Patent abstract

The present invention relates to a method of treatment of a mucopolysaccharidosis with 4-methyl-2-oxo-2H-1-benzopyran-7-yl-5-thio-β-D-xylopyranoside.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9561246 Use of Odiparcil in the treatment of a mucopolysaccharidosis

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API